C07D 401/00
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as
Official title: Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
C07D401/00 (Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as) appears on 31,426 US grants and 36,452 published applications in this corpus.
Search patents in C07D- Granted patents
- 31,426
- Published applications
- 36,452
- Assignees
- 6,463
- Inventors
- 59,900
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 96 | 0 |
| 1977 | 55 | 0 |
| 1978 | 37 | 0 |
| 1979 | 16 | 0 |
| 1980 | 22 | 0 |
| 1981 | 28 | 0 |
| 1982 | 33 | 0 |
| 1983 | 36 | 0 |
| 1984 | 91 | 0 |
| 1985 | 155 | 0 |
| 1986 | 171 | 0 |
| 1987 | 195 | 0 |
| 1988 | 235 | 0 |
| 1989 | 306 | 0 |
| 1990 | 299 | 0 |
| 1991 | 355 | 0 |
| 1992 | 276 | 0 |
| 1993 | 382 | 0 |
| 1994 | 309 | 0 |
| 1995 | 377 | 0 |
| 1996 | 446 | 0 |
| 1997 | 583 | 0 |
| 1998 | 515 | 0 |
| 1999 | 522 | 0 |
| 2000 | 522 | 0 |
| 2001 | 550 | 123 |
| 2002 | 685 | 651 |
| 2003 | 640 | 1030 |
| 2004 | 530 | 1437 |
| 2005 | 592 | 1392 |
| 2006 | 711 | 1309 |
| 2007 | 778 | 1329 |
| 2008 | 698 | 1438 |
| 2009 | 853 | 1568 |
| 2010 | 1022 | 1758 |
| 2011 | 1042 | 1550 |
| 2012 | 1214 | 1349 |
| 2013 | 1340 | 1475 |
| 2014 | 1396 | 1639 |
| 2015 | 1439 | 1671 |
| 2016 | 1273 | 1628 |
| 2017 | 1404 | 1546 |
| 2018 | 1242 | 1512 |
| 2019 | 1266 | 1600 |
| 2020 | 1260 | 1645 |
| 2021 | 1065 | 1497 |
| 2022 | 963 | 1469 |
| 2023 | 854 | 1800 |
| 2024 | 907 | 1595 |
| 2025 | 946 | 1389 |
| 2026 | 694 | 1052 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods for parasite control6 Oct 2026US 12,751,453 B2Philip Morris Products S. A.
- CDK inhibitors6 Oct 2026US 12,751,951 B2Genentech, Inc.
- PHD inhibitor compounds, compositions, and use6 Oct 2026US 12,753,161 B2Akebia Therapeutics, Inc.
- Method for producing 2-heteroarylpyridine compound6 Oct 2026US 12,753,162 B2Nippon Soda Co., Ltd.
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- Triazole compound, and preparation method therefor, herbicidal composition and use thereof8 Oct 2026US 2026/0305610 A1Qingdao Kingagroot Chemical Compound Co., Ltd.
- Anti-inflammatory compounds, pharmaceutical compositions, and methods of treating hemochromatosis and other disorders8 Oct 2026US 2026/0306470 A1Miralogx LLC
- Technologies targeting cell states8 Oct 2026US 2026/0306640 A1Auron Therapeutics, Inc.
- Bicyclic compounds8 Oct 2026US 2026/0308114 A1Vivace Therapeutics, Inc.
- Trpv4 receptor ligands8 Oct 2026US 2026/0308120 A1University of Utah Research Foundation
Most cited
By later US patents
- Pyrrolidine-containing monomers and oligomers675US 5,519,134 AIsis Pharmaceuticals, Inc. · 1996
- Pyrimidine derivatives and processes for the preparation thereof595US 5,521,184 ACiba-Geigy Corporation · 1996
- Reagent for detecting an analyte468US 7,892,748 B2Precisense A/S · 2011
- Reagent for detecting an analyte465US 8,318,443 B2Medtronic MiniMed, Inc. · 2012
- P38 inhibitors and methods of use thereof444US 7,799,782 B2Array BioPharma Inc. · 2010